The majority of new chemical entities emerging from today's drug discovery pipelines are too poorly water-soluble to enable reproducible bioavailability and efficacy after oral intake. This greatly hinders drug development and ultimately prevents patients from accessing new treatments. At Harpago, we tackle this solubility problem through rigorous formulation design and development.